Arzeda, a Seattle WA-based protein design company, raised $12m in Series A funding.
The round was led by OS Fund with participation from Bioeconomy Capital Sustainable Conversion Ventures, and WRF Capital. In conjunction with the funding, Arzeda’s board will be expanded to include Jeff Klunzinger, Co-Founder at OS Fund.
The company intends to use the funds to accelerate scale-up of its advanced protein design technology and hire additional staff to expand its business development, protein design and development operations teams, as well as fermentation and downstream process engineers.
Led by Alex Zanghellini, co-founder and CEO, Arzeda harnesses computational and synthetic biology to develop a portfolio of enzymes and specialty chemicals for polymers, advanced materials and health and nutrition products in partnership with global manufacturers, including DuPont, Mitsubishi Rayon, Invista and others, to improve crop yield and resilience, increase the performance and sustainability of nylons and reduce the cost of producing high-value food ingredients.
FinSMEs
21/07/2017